Product Details
| Alternative Name: | MOG (35-55) |
| |
| Sequence: | H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH |
| |
| Formula: | C118H177N35O29S |
| |
| MW: | 2582.0 |
| |
| Source: | Synthetic peptide. |
| |
| CAS: | 163913-87-9 |
| |
| Purity: | ≥85% (HPLC) |
| |
| Appearance: | White to off-white powder. |
| |
| Solubility: | <1mg/ml soluble in water, methanol, DMSO or dimethyl formamide. |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Immunomodulatory effects of a rationally designed peptide mimetic of human IFNβ in EAE model of multiple sclerosis: M. Poorebrahim, et al.; Prog. Neuropsychopharmacol. Biol. Psychiatry
82, 49 (2018),
Abstract;
Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming: J. Solati, et al.; Neurol. Res.
34, 478 (2012),
Abstract;
Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice: G. van Loo, et al.; Nat. Immunol.
7, 954 (2006),
Abstract;
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy: E. Zappia, et al.; Blood
106, 1755 (2005),
Abstract;
Full Text
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism: S. Pluchino, et al.; Nature
436, 266 (2005),
Abstract;
General Literature References
Synthetic peptides in the diagnosis of neurological diseases: F. Lolli, et al.; Curr. Protein Pept. Sci.
4, 277 (2003),
Abstract;
